Cite
HARVARD Citation
Low, S. et al. (2020). VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis. MAbs. 12 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Low, S. et al. (2020). VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis. MAbs. 12 (1), p. . [Online].